Arsenic trioxide and acute promyelocytic leukemia:: Clinical and biological

被引：0
|
作者：
Chen, Z.
Zhao, W-L.
Shen, Z-X.
Li, J-M.
Chen, S-J.
Zhu, J.
Lallemand-Breittenbach, V.
Zhou, J.
Guillemin, M-C.
Vitoux, D.
de The, H.
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Rui Jin Hosp, Sch Med, Shanghai 200025, Peoples R China
[2] Hop St Louis, CNRS, UMR 7151, Hop St Louis, F-75475 Paris, France
来源：
ACUTE PROMYELOCYTIC LEUKEMIA: MOLECULAR GENETICS, MOUSE MODELS AND TARGETED THERAPY | 2007年 / 313卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Arsenic has recently been identified as an effective drug in the treatment of newly diagnosed and relapsed acute promyelocytic leukemia. Indeed, arsenic trioxide combined with all-trans retinoic acid shows a synergistic effect. Mechanistically, arsenic targets the key leukemogenic protein PML-RAR alpha, setting up a new example of molecular target-based cancer therapy.
引用
收藏
页码：129 / 144
页数：16
相关论文
共 50 条
  • [21] Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
    E Lengfelder
    W-K Hofmann
    D Nowak
    Leukemia, 2012, 26 : 433 - 442
  • [22] Arsenic trioxide in acute promyelocytic leukemia: potion not poison
    Powell, Bayard L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1317 - 1319
  • [23] Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
    Lengfelder, E.
    Hofmann, W-K
    Nowak, D.
    LEUKEMIA, 2012, 26 (03) : 433 - 442
  • [24] Clinical observation on arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
    Ma, J
    Jin, MH
    Chen, LY
    Liang, H
    Zhang, Y
    BLOOD, 1998, 92 (10) : 404A - 404A
  • [25] Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical results and open questions
    Lengfelder, Eva
    Hofmann, Wolf-Karsten
    Nowak, Daniel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (09) : 1035 - 1043
  • [26] Early application of arsenic trioxide improved the clinical outcomes of acute promyelocytic leukemia
    Chen, Hongli
    Wang, Xiaman
    Huang, Tianhe
    Liu, Jing
    Shen, Ying
    Feng, Yuandong
    Zhang, Wanggang
    Song, Yanping
    Chen, Yinxia
    Cao, Xinmei
    Yang, Yun
    Wang, Jianli
    Ma, Xiaorong
    Liu, Jie
    Bai, Ju
    He, Aili
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (10): : 14579 - 14585
  • [27] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    倪建华
    陈国强
    沈志祥
    李秀松
    刘海卫
    黄燕婷
    方智雯
    陈赛娟
    王振义
    陈竺
    中华医学杂志(英文版), 1998, (12) : 51 - 54
  • [28] Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Hunt, Daniel P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1866 - 1866
  • [29] Hepatotoxicity From Arsenic Trioxide for Pediatric Acute Promyelocytic Leukemia
    Hao, Liangchun
    Zhao, Jishu
    Wang, Xiuli
    Wang, Hong
    Wang, Huan
    Xu, Gang
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (02) : E67 - E70
  • [30] Arsenic trioxide: Pharmacokinetics in acute promyelocytic leukemia (APL) patients
    Ghiuzeli, Cristina Maria
    Calabro, Anthony
    Saunders, Randall Jesse
    Budman, Daniel R.
    Styblo, Miroslav
    Devoe, Craig E.
    Allen, Steven L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345